We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GFC:EURONEXT PARISGecina SA Analysis

Data as of 2026-03-14 - not real-time

THB 2.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The price is trading just above the short‑term moving average while remaining below the long‑term moving average, signaling a neutral to slightly bearish bias. Momentum indicators show an RSI below the midpoint and a negative MACD histogram, suggesting limited upward pressure. Volume has been trending lower, which can exacerbate price weakness in a sideways market. Recent volatility is elevated, reflecting sizable price swings. A near‑zero beta indicates that price movements are largely independent of broader market trends, adding idiosyncratic risk. Historical drawdowns have been deep, underscoring the potential for sharp declines. The prevailing market sentiment index leans toward greed, implying optimism that may be disconnected from fundamentals.
Fundamentally, the company posted a decline in revenue, and its margins, while positive, are modest. Operating cash flow remains positive, yet free cash flow is limited, raising questions about sustainable growth. The dividend payout exceeds earnings, rendering the current yield unsustainable over the long run. Valuation models place the intrinsic value well below the current market price, indicating that the stock is overvalued. Given the sector’s stable demand but regulatory and geographic exposure, the outlook remains cautious.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical momentum
  • High dividend payout ratio
  • Price above intrinsic valuation

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained overvaluation
  • Modest cash generation
  • Sector stability

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Unsustainable dividend policy
  • Continued revenue decline risk
  • Potential regulatory changes

Key Metrics & Analysis

Financial Health

Revenue Growth-7.90%
Profit Margin6.35%
P/E Ratio29.0
ROE4.64%
ROA3.11%
Debt/Equity5.10
P/B Ratio1.1
Op. Cash FlowTHB63.9M
Free Cash FlowTHB13.5M
Industry P/E26.2

Technical Analysis

TrendNeutral
RSI43.2
SupportTHB 2.80
ResistanceTHB 3.18
MA 20THB 3.00
MA 50THB 2.90
MA 200THB 3.40
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueTHB 1.29
Target PriceTHB 3.50
Upside/Downside20.69%
GradeOvervalued
TypeValue
Dividend Yield4.48%

Risk Assessment

Beta-0.01
Volatility27.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.